Akili to Participate in LifeSci Partners HealthTech Symposium
19 September 2022 - 09:00PM
Business Wire
Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company,
today announced that management will present at a fireside chat and
participate in a panel discussion on prescription digital
therapeutics at the virtual LifeSci Partners HealthTech Symposium
on Tuesday, September 20, 2022.
Details are as follows:
Format: Presentation and Fireside Chat Time: 9:30
a.m. ET
Format: Panel Discussion Topic: Prescription
Digital Therapeutics Time: 11:30 a.m. ET
Live and archived webcasts of the fireside chat and panel
discussion will be available on the Investors section of Akili’s
website at www.akiliinteractive.com.
About Akili
Akili is pioneering the development of cognitive treatments
through game-changing technologies. Our approach of leveraging
technologies designed to directly target the brain establishes a
new category of medicine – medicine that is validated through
clinical trials like a drug or medical device but experienced like
entertainment. Akili’s platform is powered by proprietary
therapeutic engines designed to target cognitive impairment at its
source in the brain, informed by decades of research and validated
through rigorous clinical programs. Driven by Akili’s belief that
effective medicine can also be fun and engaging, Akili’s products
are delivered through captivating action video game experiences.
For more information, please visit www.akiliinteractive.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220919005164/en/
Investor Contact: Joshua Young VP of Investor Relations
jyoung@akiliinteractive.com
Media Contact: Julie DiCarlo SVP, Communications
julie@akiliinteractive.com
Akili (NASDAQ:AKLI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Akili (NASDAQ:AKLI)
Historical Stock Chart
From Mar 2023 to Mar 2024